Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown ...

Pfizer and GSK’s RSV vaccines have a new warning at the request of the FDA, relaying an increased risk to Guillain-Barré ...

Astellas has ended work on a cell therapy that it was exploring for CD20-positive B cell lymphomas, the Japan-based pharma ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%.

National Resilience is laying off 120 staffers from its gene therapy facility in North Carolina, only a month after the San ...

Sana stock soars on diabetes therapy data, UniQure's offering, BioInvent's lymphoma success, Alpha's Zunveyl deal, Neumirna funding, and Cassava's layoffs.

A new startup aiming to tackle rare diseases de-stealthed Wednesday morning with a CEO experienced in the space. Alesta ...

Roche's Chugai partners with Araris Biotech on multi-payload ADCs, as Swiss biotech advances tech allowing multiple cytotoxic ...

Tenvie Therapeutics launches with $200M, acquires Denali drug candidates, led by Tony Estrada with NLRP3 and SARM1 inhibitors ...

Aspect Biosystems raises $115M Series B for bioprinted tissue therapeutics targeting diabetes and metabolic disorders, led by ...

Ahead of the busiest week for biopharma dealmaking at the annual JP Morgan Healthcare Conference, a new startup launched, ...